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a  b  s  t  r  a  c  t
Excitable  cells  typically  possess  junctional  membrane  complexes  (JMCs)  constructed  by the  plasma  mem-
brane and  the  endo/sarcoplasmic  reticulum  (ER/SR)  for  channel  crosstalk.  These  JMCs  are  termed  triads  in
skeletal  muscle,  dyads  in cardiac  muscle,  peripheral  couplings  in  smooth  and  developing  striated  muscles,
and subsurface  cisterns  in neurons.  Junctophilin  subtypes  contribute  to  the  formation  and  maintenance  of
JMCs  by  serving  as  a physical  bridge  between  the  plasma  membrane  and  ER/SR  membrane  in  different  celleywords:
uscle
alcium channel
xcitation–contraction coupling
types.  In muscle  cells,  junctophilin  deﬁciency  prevents  JMC  formation  and  functional  crosstalk  between
cell-surface  Ca2+ channels  and  ER/SR Ca2+ release  channels.  Human  genetic  mutations  in junctophilin
subtypes  are  linked  to congenital  hypertrophic  cardiomyopathy  and  neurodegenerative  diseases.  Fur-
thermore,  growing  evidence  suggests  that  dysregulation  of  junctophilins  induces  pathological  alterations
in  skeletal  and  cardiac  muscle.
ublis©  2015  The  Authors.  P
. Junctional membrane complexes in excitable cells
.1. Coupling between plasma membrane and endo/sarcoplasmic
eticulum
Junctional membrane complexes (JMCs) are structural contacts
etween the plasma membrane (PM) and the endo/sarcoplasmic
eticulum (ER/SR), ﬁrst observed in muscle cells by Porter and
alade in the mid-50s [1]. Subsequent studies have identiﬁed sev-
ral types of JMCs widely in excitable cells [2], including “subsurface
isterns” in neurons [3]. The best-characterized function of JMCs is
he coupling of electric excitation of the PM to myoﬁlament con-
raction (E-C coupling) through SR Ca2+ release in muscles [4,5].
ecent studies demonstrate that JMCs are also transiently con-
tructed in nonexcitable cells, and these unstable JMCs play an
ssential role in the store-operated Ca2+ entry mechanism [6]..2. Muscle-speciﬁc membrane complexes
In striated muscles, JMCs are highly specialized and have
een extensively characterized. In adult mammalian ventricular
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cardiomyocytes, JMCs are located in two  distinctive subcellular
compartments: “peripheral couplings” occur directly underneath
the PM,  whereas “dyads” occur between the tubular invaginations
of the PM (termed transverse-tubules: T-tubules) and the ER/SR
in the cytosol. The terminal ER/SR cisternae in cardiac JMCs are
ﬂat (∼20 nm in width) and ﬁlled with characteristic “beaded gran-
ules” comprised of calsequestrin (Fig. 1) [7]. Cardiac T-tubules are
∼70–250 nm in diameter in rodents and ∼400 nm in large animals
and develop along the Z-line of the myoﬁbril while constituting
dyads with ER/SR [8–11]. Cardiac T-tubules are thought to play
an important role in conducting PM depolarization inward to the
cell center and synchronizing dyad activation cell-wide. JMCs in
skeletal muscle are generally shaped as “triads”, consisting of two
ER/SR sacs ﬂanking a ﬂat T-tubule and located at the A-I junction
of myoﬁbril assembly (Fig. 1) [12]. T-tubules are mostly generated
during postnatal development both in skeletal and cardiac mus-
cles and this is coordinated with the cytoplasmic appearance of
JMCs [13,14]. It is, however, not clear whether the tip of T-tubules
randomly elongates and forms dyads, or if there is an active mech-
anism to attract T-tubules to preexisting ER/SR cisterns tethered to
the sarcomere via obscure molecular mechanisms.
In both cardiac dyads and skeletal triads, the gap between T-
tubules and ER/SR cisternae is consistently 12–15 nm in depth and
ﬁlled with periodical projections termed “feet” that bridge the two
membranes. After the initial description of the feet by electron
microscopy, it took a couple of decades to realize that the ryanodine
receptor (RyR), a ∼565 kDa tetramer and a primary Ca2+ release
channel in the ER/SR membrane, makes up the “foot structure” in
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Junctional membrane complexes (JMCs) in striated muscles. Two  types of three-dimensional (3D) electron microscopy (EM) technologies (EM tomography and serial
block-face scanning EM)  are used to demonstrate JMC  nano 3D architectures in tibia anterior muscle (A, B) and in ventricular muscle (C, D) obtained from adult mice. Triads
consisting of the terminal cisternae of the SR and T-tubules are located at the junction of A-band and I-band in fast skeletal muscles (A). The triad structure is depicted as a 3D
geometric model reconstructed in EM tomography in B. In contrast, cardiac dyads formed by T-tubules and SR, are located near Z-lines (C, EM tomography) [8] and are widely
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a2+ channel molecules in JMCs in cardiac muscle. DHPR, dihydropyridine receptor
unctional SR; PM,  plasma membrane; Nuc, nucleus.
uscular JMCs (reviewed in [15]). We  now understand that dyads
nd triads anatomically represent “couplons”, which are theoret-
cally proposed cellular nano-units to explain the two conﬂicting
atures of muscle regulation: the robustness and the dynamism of
he E–C coupling gain control [16,17]. In cardiac muscle, dihydropy-
idine receptors (DHPRs), voltage-dependent l-type Ca2+ channels,
nd RyRs are functionally linked in a diffusion-limited narrow JMC
pace via a mechanism termed Ca2+-induced Ca2+ release (CICR)
5,18]. In skeletal muscle, on the other hand, the direct interac-
ion between DHPRs and RyRs converts the depolarization signal
nto SR Ca2+ release through a voltage-induced Ca2+ release (VICR)
echanism [4]
.3. Molecules maintaining JMC  structures in muscles
There was early speculation that RyRs constitute JMCs through
heir physical interaction with PM proteins, such as DHPRs, or T-
ubule membrane. However, this working hypothesis was refuted
y studies in skeletal muscles obtained from mutant mice lack-
ng either skeletal DHPR (“dysgenic”) or RyR1 (“dyspedic”) [19].
he size and the frequency of JMCs are reduced in these mutant
ice, but junctions remain structured. Structural changes in JMCs
ave also been reported in other mutant mouse strains in which
yR-interacting proteins, such as calsequestrin and triadin, are
enetically ablated. In Casq1-null mice, skeletal muscle triads are
igniﬁcantly deformed and unique multilayered JMCs are observed
n fast-twitch muscles [20]. In contrast, the frequency and extent of
MCs are largely preserved in Casq2-null cardiomyocytes, although
R cisternae are signiﬁcantly enlarged in these cells [21]. In Trdn-
ull mice, the number and the size of dyadic junctions are reduced
n cardiomyocytes [22], while triad alteration is subtler in skeletal
uscles [23]. Speciﬁcally, triad orientation is modiﬁed and calse-
uestrin is occasionally mis-localized in triadin-deﬁcient skeletal
uscle cells [23].
In addition to SR/ER-associated proteins, several PM proteins
ave reported roles in JMCs. A part of peripheral JMCs are associated
ith the ∼70–90 nm vesicular invaginations termed caveolae inscanning EM)  [24]. E schematically shows the structure of JMCs and distribution of
, ryanodine receptor; JP2, junctophilin 2; ER/SR, endo/sarcoplasmic reticulum; jSR,
cardiac muscle [24]. Consistently, mouse deﬁciency in caveolin-3,
which is an essential protein for caveolae formation in striated mus-
cles, deforms T-tubules and mis-localizes JMC channel molecules
in skeletal muscle [25] and degenerate cells in cardiac muscle [26].
Bridging integrator 1 (BIN1, also termed amphiphysin 2) is a con-
served member of the BAR-domain family that has multiple splicing
isoforms with diverse biological functions [27] and loss of Bin1 has
been documented in failing hearts [28]. Heterologous expression of
BIN1 forms narrow tubular extensions of the PM into the cytoplasm
in Chinese hamster ovary cells [29]. A recent study genetically sup-
pressed BIN1 expression in mouse cardiomyocytes and found struc-
turally altered T-tubules [30]. The study also implicated that a par-
ticular BIN1 isoform, BIN1+13+17, contributes membrane foldings
in T-tubules [30]. Finally, mouse genetic ablation of MG29, which is
also termed synaptophysin-like 2 and is a synaptophysin-like pro-
tein expressed in skeletal muscle selectively [31], causes enlarged
T-tubules, vacuolar ER/SR, and triad disarray in muscles [32].
Although these SR/ER and PM proteins have their clear roles
in the regulation of JMCs, established evidence suggests that the
association of the T-tubule and SR/ER membranes is primarily
established by junctophilins, as reviewed in detail in the following
sections.
2. Junctophilin subtypes
2.1. Structure of junctophilin (JP) and its JMC-forming function
Junctophilin type 1 (JP1), the inaugural member of the family
proteins, was ﬁrst identiﬁed in the junctional SR fraction of rabbit
skeletal muscle [33]. After cloning rabbit JP1, database searches
and homology cloning identiﬁed and clariﬁed tissue-speciﬁc JP
family members, namely JP1-4 [34]. The JP subtype genes are
currently designated as JPH1-4 in the human and Jph1-4 in the
mouse genomes, respectively. The primary structure of JP subtypes
is largely hydrophilic and possesses a large cytoplasmic domain
(Fig. 2A). JP subtypes share conserved sequences of 14 amino acid
residues, termed MORN motifs, which repeat eight times in the
N-terminal region composed of ∼330 amino acid residues [33]. The
H. Takeshima et al. / Cell Calcium 58 (2015) 349–356 351
Fig. 2. Structure and function of junctophilin. (A) Hydropathicity proﬁle of rabbit JP1 [48]. Repeated MORN motifs and an SR membrane-spanning segment are indicated.
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tB)  Proposed JP structure in junctional membrane complex. (C) Phylogeny tree of ju
enes  encoding tissue-speciﬁc junctophilin subtypes (JP1–JP4) in vertebrates. The 
abbit  JP1 in amphibian embryonic cells [48]. Exogenous JP1 proteins are localized
he  C-terminal transmembrane segment remains tethered to the PM (upper right p
-terminal MORN motif region is followed by a putative -helical
egion (∼100 residues), a divergent region of 215–292 residues
ith no homology between the subtypes, and a C-terminal trans-
embrane segment that spans the SR/ER membrane (Fig. 2B).
P family proteins are found across animal species; vertebrates
ncluding human and mouse share four JP subtype genes and there
s a single JP gene in invertebrates (Fig. 2C).
In a study using amphibian embryos, overexpressed JP1 was
etected at the cell periphery by immunohistochemistry and
fﬁciently formed JMCs reminiscent of peripheral couplings and
ubsurface cisternae (Fig. 2D). In contrast, a deletion mutant of
P1, which lacks the C-terminal transmembrane segment, local-
zed along the cell membrane but did not generate JMCs. These
ata suggest that ectopically expressed JP1 binds to the cell mem-
rane, spans the SR/ER membrane, and thereby forms JMCs. The
-terminal region of both JP1 and JP2, which includes the eight
ORN motifs, tightly interacts with phosphatidylinositol phos-
hate species as evidenced by biochemical assays [33,35,36]. The
ORN motif region is also necessary for the binding of plant phos-
hatidylinositol monophosphate kinase to phosphatidic acid and
hosphatidylinositol phosphate species [37]. Therefore, the com-
on  function of repeated MORN motifs seems to be the recognition
f phospholipids, and the attachment of JPs with the cell mem-
rane may  be due to a direct interaction of the MORN motifs
ith membrane lipids. Interestingly, in contrast with the embry-
nic cells, exogenous JP expression has failed to form JMCs in
everal commonly used mammalian cell lines (Takeshima et al.,
npublished observations). This cell-type speciﬁcity may  be due to
he abundance of PM-associated cytoskeletal proteins in mature
ukaryotics. The PM-associated cytoskeletal proteins are largely
bsent in cleavage cells in fertilized eggs and it remains unclear
ow JP preferentially generate JMCs at the PM in excitable cells.
ecent studies suggest the direct interaction of JP subtypes with
aveolins, DHPRs, and RyRs [38–41], contributes to the formation
f JMCs and thereby to the regulation of Ca2+ handling in muscle
ells. The biological role of these protein–protein interactions in the
ynthesis and maintenance of JMCs remains to be fully elucidated..2. JP-mediated Ca2+ microdomains
Previous studies using knockout mice demonstrated that JP sub-
ypes are necessary to establish RyR-mediated channel crosstalkilin proteins. Invertebrates contain a single junctophilin gene, while there are four
ﬁed tree is adapted from a previous publication [86]. (D) Functional expression of
 cell periphery and form ER-PM complexes (upper left panel). Mutant JP1 lacking
 but no junctional membrane complex is formed (lower panel).
in JMCs in excitable cells (Fig. 3). In adult mice, JP2 is expressed
throughout muscle cell types, including skeletal, cardiac and
smooth muscle cells, and is localized in dyads in the cardiac mus-
cle and in triads in the skeletal muscle. Jph2-null mice die during
the early embryonic development due to cardiac failure [33]. Car-
diomyocytes from Jph2-null embryos have defective peripheral
coupling, abnormal SR Ca2+ releases, and impaired CICR during E–C
coupling [33]. Therefore, JP2 is essential for both peripheral cou-
pling formation and functional crosstalk between DHPRs and RyRs
in the embryonic heart. Consistent with the ﬁndings in the Jph2-
null embryos, JP2 was  shown to contribute to dyad formation and
its stabilization in neonatal and adult cardiomyocytes (see Section
3.1). Indeed, one mechanism for the E–C coupling dysfunction in
Jph2-null hearts is impaired maturation of the T-tubule membrane
network [42,43].
Both JP1 and JP2 are abundantly expressed in adult skeletal mus-
cle. While JP2 is ﬁrst expressed in utero, JP1 expression is highly
inducible during the postnatal development. Jph1-null mice dis-
play sucking failure and die shortly after birth [44]. The skeletal
muscle of the Jph1-null neonates is characterized by poor triad
formation and lowered VICR efﬁciency. Therefore, during skeletal
muscle development, JP2 mediates peripheral coupling and dyad
formation in embryonic and perinatal stages, and then JP1 likely
plays an essential ole in the postnatal triad formation and the estab-
lishment of efﬁcient VICR [45]. It is noteworthy that JP1 is not able
to mediate the conversion of dyads to triads, as shown in a JP1
overexpression study in cardiomyocytes [46].
JP3 and JP4 are widely expressed in neurons in the brain
[34]. Knockout mice lacking either JP3 or JP4 show no obvious
abnormalities, suggesting functional redundancy between JP3 and
JP4. However, double-knockout mice lacking both Jph3 and Jph4
(Jph3/4-DKO mice) have severe growth retardation and die within
3–4 weeks after birth under normal housing conditions [47]. Jph3/4-
DKO mice are rescued when the diet is switched from normal
pellets to hydrated paste. Therefore, the lethality of weaning Jph3/4-
DKO mice is probably caused by a feeding defect associated with
the functional impairment of the neuronal circuit controlling mas-
tication or salivary secretion. Jph3/4-DKO mice also have impaired
performance in learning and memory tasks and abnormal excitabil-
ity and synaptic plasticity in hippocampal neurons. In hippocampal
CA1 neurons, which receive excitatory inputs from CA3 neu-
rons, afterhyperpolarization (AHP) is generated by Ca2+-dependent
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Fig. 3. Channel signalosomes in JMCs organized by JP subtypes. The hypothetical mechanisms are based on the data from knockout mice lacking ryanodine receptor or
junctophilin subtypes. Channel communication in junctophilin-mediated membrane complexes may  have gained functional diversity during the development of excitable
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+ channel; NMDAR, N-methyl-d-aspartate receptor channel; CaM, calmodulin; Tn
hannel crosstalk between N-methyl-d-aspartate receptors, RyRs,
nd small-conductance Ca2+-dependent K+ channels (SK channels)
Fig. 3). This three-channel crosstalk is functionally disintegrated
n Jph3/4-DKO CA1 neurons, thereby preventing the induction of
ong-term potentiation triggered by a high-frequency stimulation
47]. These observations, together with pathological phenotypes
ound in the cerebellar Purkinje neurons and striatum neurons
f Jph3/4-DKO mice [48,49], indicate that both JP3 and JP4 coor-
inately form subsurface cisternae to establish Ca2+-dependent
rosstalk between PM and intracellular channels as a machinery
or AHP in neurons. Similar machinery is found in hyperpolarization
ignaling of smooth muscle [50]. In smooth muscle cells, sponta-
eous opening of RyRs activates big-conductance Ca2+-dependent
+ (BK) channels to induce PM hyperpolarization. Interestingly, this
everse-mode signaling seems to require JP2-mediated peripheral
oupling, while Ca2+ inﬂux via DHPRs does not directly activate
yRs in smooth muscle cells [50]. Cellular and molecular mech-
nisms supporting the crosstalk between RyRs and BK channels
n smooth muscle and their relationship with peripheral coupling
arrant further investigations.
Depletion of the intracellular Ca2+ store in the ER/SR acti-ates so-called store-operated Ca2+ entry (SOCE), a physiological
echanism involved in maintaining Ca2+ inﬂux through the PM
nd reﬁlling the ER/SR Ca2+ store in various cell types. SOCE is
oordinated through a direct interaction between two  distinctonductance Ca2+-dependent K+ channel; SK Ch, small-conductance Ca2+-dependent
onin C.
membrane proteins, the ER Ca2+ sensor STIM and the Ca2+ chan-
nel Orai expressed in PM [51,52]. In response to store depletion,
STIM undergoes a dynamic redistribution into discrete ER domains
juxtaposed closely with the PM.  Orai then becomes tethered by
clustered STIM proteins within the ER–PM junctions and mediates
Ca2+ entry. Although SOCE is largely preserved under JP2 deﬁciency
in embryonic cardiomyocytes [53], recent studies indicate that JPs
facilitate SOCE by stabilizing the ER/SR–PM junctions in excitable
cells. In skeletal muscle, JP1 and JP2 seem to coordinately enhance
SOCE activity [54,55]. Furthermore, JP1, which is expressed weakly
in neurons, seems to similarly enhance SOCE in this cell type [56].
3. Junctophilin-related diseases
3.1. JP2 and cardiac diseases
Of the JP subtypes, JP1-3 have been found to play impor-
tant roles in human pathology. In addition to its role in normal
development of cardiac E–C coupling machinery, JP2 is a critical
safeguard of cardiac ultrastructure and function in response to
cardiac stress. JP2 dysregulation has been associated with variety
of heart diseases. In human failing heart samples such as those
from patients with hypertrophic, dilated or ischemic cardiomy-
opathy, JP2 is severely downregulated as compared to trauma
or “healthy” donor hearts [57,58] (and Song et al., unpublished
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bservations). Moreover, the expression of JP2 is markedly reduced
n response to cardiac stress in multiple animal models of cardiac
isease, e.g., pressure overload or myocardial infarction-induced
odent hypertrophy/heart failure models and genetically modi-
ed murine models of hypertrophic or dilated cardiomyopathy
10,38,59–64]. Cardiac stress can also cause mis-trafﬁcking of JP2
n failing myocytes, including loss of localization in the T-tubule/Z-
ine region and redistribution to the peripheral plasma membrane
65].
Emerging evidence suggests that both loss of JP2 expression and
is-localization contribute to structural and functional alterations
f cardiomyocytes and the development of heart failure. First,
nduced reduction in JP2 expression in cultured cardiomyocytes
sing viral transfection of JP2 shRNA results in a signiﬁcant decrease
n the coupling or contact area between T-tubules and the junc-
ional SR [66], which is consistent with the primary role of JP2 in
he formation of JMCs. Second, JP2 knockdown results in a concomi-
ant disorganization of the T-tubule network in cardiomyocytes
60,67]. The interpretation of these data is that JP2 is also essen-
ial in maintaining the stability of the organized T-tubule network
y tethering the T-tubule membrane with the junctional SR [68].
hird, in line with its effects on E–C coupling architecture, in vitro
P2 silencing ablates myocyte CICR function, with decreased and
yssynchronous Ca2+ transients [58,66]. Fourth, acute JP2 knock-
own in adult transgenic mice expressing JP2 shRNA leads to rapid
evelopment of heart failure and a high incidence of sudden car-
iac death, which is associated with a disrupted T-tubule system,
ecreased frequency of JMCs, increased variance of the coupling
istance within JMCs and compromised E–C coupling function
69]. Furthermore, recent studies provide compelling evidence that
ltered JP2 localization also contributes to T-tubule remodeling
nd Ca2+ handling defects in both in vitro cultured cardiomyocytes
nd pathological heart failure models [64,65,70]. These ﬁndings
re in accordance with the fundamental function of JP2 in the T-
ubule/junctional SR regions. On the other hand, cardiac-speciﬁc
verexpression of JP2 doubles the contact length and frequency
f T-tubules/junctional SR-coupled dyads and protects against T-
ubule remodeling and heart failure development in response to
ressure overload stress [71].
Mutations in the JPH2 coding region have been implicated in
P2 dysregulation and associated with familial hypertrophic car-
iomyopathies. Seven distinct mutations (S101R, Y141H, S165F,
169K, A405S, R436C and G505S) have been identiﬁed in patients
ith cardiac hypertrophy [41,72,73]. Patients with the JPH2 muta-
ion E169K also present with paroxysmal atrial ﬁbrillation or
upraventricular tachycardia [41]. These mutations most likely
erturb intracellular Ca2+ handling of myocytes. In HL-1 cells,
denovirus-mediated expression of JP2 mutants (S101R, Y141H or
165F) causes a marked reduction in the frequency and amplitude
f spontaneous Ca2+ release and cardiomyocyte hyperplasia [73].
n skeletal myotubes, expression of JP2 mutants (Y141H, S165F)
imilarly leads to a dramatic decrease in peak amplitude of Ca2+
ransients and a signiﬁcant increase in resting cytosolic Ca2+ con-
entration as well as an increase in myotube diameter [74,75]. What
emains unclear, however, is how mutations of a structural protein,
specially the mutations located in MORN or joining regions, result
n disrupted Ca2+ signaling in affected cells. Studies from Wehrens
roup suggest that JP2 binds to and stabilizes RyR2 under normal
onditions [69], and the E169K mutation causes a reduced bind-
ng of JP2 to RyR2 and thus decreased JP2-mediated stabilization of
yR2 and increased RyR2-mediated SR Ca2+ leak [41]. The JP2 S101R
utation results in a conformational change in the secondary struc-ure, which alters its afﬁnity to certain lipids, with an increased
fﬁnity for phosphatidylserine [36]. While it has been postulated
hat this increased afﬁnity alters other JP2–protein interactions,
ow this type of mutation-associated JP2 modiﬁcation contributesFig. 4. Mechanisms underlying JP2 dysregulation in heart disease. Depicted are
miRNA-mediated gene silencing by miR-24, calpain-mediated proteolysis, and re-
distribution to the cell periphery in response to microtubule polymerization.
to altered E–C coupling function in cardiomyocytes is completely
unknown.
3.2. Mechanisms of JP dysregulation in cardiac and skeletal
muscle diseases
Control of JP2 expression is complex, and several mechanisms
have been reported in the literature to explain the loss of JP2 in
failing hearts (Fig. 4). The ﬁrst report demonstrated that JP2 is
targeted by the microRNA mir-24, which may be responsible for
downregulation of JP2 during pressure overload-induced hypertro-
phy [61]. miR-24 is one of the miRNAs that is upregulated in failing
hearts [61,76], and its upregulation coincides with downregulation
of JP2 [57,61]. Conﬁrming the relationship between miR-24 and JP2,
in vivo silencing of miR-24 with an antagomir prevents progression
of pressure overload-induced heart failure through maintenance of
JP2 expression and T-tubule/junctional SR integrity [77].
Downregulation of JP2 in failing hearts has also been attributed
to cleavage by calpain [64], a protease that is activated by ele-
vated intracellular Ca2+ in many different forms of cardiac stress
and stress-response models [78,79]. In a transgenic mouse with
inducible activation of Gq, loss of T-tubule integrity is associated
with a pronounced decrease in full-length JP2 and the appearance
of a faster-migrating cleavage fragment, whereas cessation of Gq
activation restores full-length JP2 expression and T-tubule integrity
[64]. The ability of a calpain inhibitor to prevent Gq-mediated JP2
downregulation in vivo identiﬁes calpain as the protease that is
responsible for generation of the JP2 cleavage fragment. Further
analysis with mass spectrometry revealed that cleavage occurs at
amino-terminal site 201–202 (leucine/leucine). These data are in
2+line with a previously reported Ca -dependent mechanism for JP1
and JP2 proteolysis in skeletal muscle [80]. In this study by Lamb
and associates, increasing [Ca2+] promotes proteolysis of JP1, which
corresponds with increased -calpain (calpain I) autolytic activity.
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P1 proteolysis is accelerated in the mdx  model of muscular dys-
rophy. Extending studies to JP2, in vitro exposure of ventricular
ardiomyocytes to increasing [Ca2+] or in vivo ischemia-reperfusion
njury results in a decrease in full-length JP2 levels, though no cleav-
ge fragment was detected [80].
Another mechanism underlying dysregulation of JP2 is loss of
ormal subcellular localization due to microtubule polymerization
65]. Alterations in microtubules, namely microtubule densiﬁcation
an increase in microtubule density due to enhanced microtubule
olymerization), are commonly observed in human failing hearts
nd animal models of heart failure [81,82]. The recent study by
hang et al. [65] reveals that the subcellular distribution of JP2 is
echanistically linked to microtubule dynamics. In response to car-
iac stress, the densiﬁcation of the microtubule network results
n redistribution of JP2 within the membrane system, thereby
nducing T-tubule remodeling and E–C coupling dysfunction and
ontributing to the development of heart failure. Furthermore, this
tudy indicates that the microtubule motor protein kinesin 1, which
s critical for protein anterograde trafﬁcking, is responsible for
icrotubule densiﬁcation-mediated JP2 mis-trafﬁcking [65].
.3. JPs and neurological diseases
Huntington’s disease-like 2 (HDL2), like the authentic Hunting-
on’s disease, is a progressive neurodegenerative disorder clinically
haracterized by abnormal movements, dementia and psychiatric
yndromes. Studies have linked triplet-repeat expansion mutations
n the JPH3 locus to HDL2, which results in the expansion of polyg-
utamine encoded by the JPH3 antisense strand and disruption of
he JPH3 sense strand [83,84]. Both JP3 and JP4 likely exert compen-
atory roles in neural sites of the brain, although their distributions
nd expression densities are slightly different [34]. As described
n Section 2.2, Jph3-null mice show no obvious phenotype in young
dult stages. However Jph3-null mice exhibit behavioral and patho-
ogical defects in old age. These mouse observations support the
dea that JP3 deﬁciency and certain aging effects, such as accumu-
ative tissue oxidation caused by the production of reactive oxygen
pecies, synergistically leads to the late-onset neurodegeneration
bserved in HDL2 patients [85]. The neural phenotype of Jph3/4-
KO mice is discussed in Section 2.2.
Charcot-Marie-Tooth disease (CMT) is an umbrella term for a
ange of certain inherited genetic disorders that affect the periph-
ral nervous system. A recent study found that JP1 is likely involved
n the pathogenesis of CMT  [56]. This study found that the JPH1 gene
s genetically associated with ganglioside-induced differentiation-
ssociated protein 1 (GDAP1), mutations of which are found in a
ubset of CMT  patients. JP1 serves as a potential modiﬁer of the
linical variability of GDAP1 mutation-associated CMT  [56].
. Perspective
Recent studies have deﬁned basic functions of JMCs organized
y JP subtypes in excitable cells, and also unveiled associations and
ausal roles for JPs in cardiac and neurological diseases. However,
here remain many questions to be addressed in future studies: how
s the structure of T-tubules maintained by JPs in muscles? How are
Ps concentrated in the junctional cisternae of ER/SR? Are there any
P-binding partners other than phospholipids to assist in JMC  for-
ation? Which protein factors determine dyad and triad formation
n striated muscle? What are pathophysiological mechanisms of
ypertrophic cardiomyopathy caused by JPH2 mutations? Are there
ny genetic and environmental factors that cooperate with JPH3
utations to induce HDL2? These and other questions inevitably
rovide a future challenge in understanding the physiological and
athological roles of JPs in health and disease.
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